Tyler Sloan earned his B.Sc. and Ph.D. from McGill University. Instead of doing a traditional postdoctoral fellowship, he founded Quorumetrix, a scientific data analysis and visualization studio based in Montréal. He specializes in data visualization and 3D animation, presenting primary research data in an attractive and engaging way while maintaining robust scientific accuracy. His award-winning visualizations have been featured in prominent academic journals and conferences. Sloan embraces a generalist approach and loves the challenge of exploring new data types, and he is particularly passionate about full-dome visualization.
Tyler Sloan
Data scientist
Quorumetrix
From this contributor
To develop better nervous-system visualizations, we need to think BIG
With a full mouse connectome on the horizon, neuroscience needs to overcome its legacy of minimalism and embrace the contemporary challenge of representing whole-nervous-system connectivity.
To develop better nervous-system visualizations, we need to think BIG
By
Tyler Sloan
8 July 2024 | 8 min read
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read